Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

Go back to Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update
(NYSE: RCUS) Delayed: 18.54 -0.82 (4.24%)
Previous Close $19.36    52 Week High $ 
Open $19.02    52 Week Low $ 
Day High $19.09    P/E N/A 
Day Low $18.43    EPS $ 
Volume 5,925,218